Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Therapy of Helicobacter pylori infection (CROSBI ID 92290)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Katičić, Miroslava Therapy of Helicobacter pylori infection // Gastroenterology international, 13 (2000), 3; 1-x

Podaci o odgovornosti

Katičić, Miroslava

engleski

Therapy of Helicobacter pylori infection

Abstract. The clinical significance of H. pylori infection in the etiopathogenesis of many gastric and duodenal diseases, peptic ulcer in particular, as well as the current awareness of the benefits of its eradication has produced crucial changes in the treatment of these diseases. Eradication was already defined as the disappearance of H. pylori from the gastric mucosa (finding negativization) confirmed at least 4 weeks (or later) after completed antibiotic eradication therapy. The regimen has to be simple, cheap and tolerable so that the patient could carry it out completely and as easy as possible (good compliance is required). The success of H. pylori eradication, evaluated by the strict "intention-to-treat" criteria, has to be higher than 80%. Current modern therapy should be triple and not longer than 7 days. One of three proton pump inhibitors is recommended as the antisecretory component (omeprazole, pantoprazole or lansoprazole). Two of three following antibiotic is added to this therapy: metronidazole/tinidazole, clarithromycin or amoxicillin.

Helicobacter pylori; therapy; eradication

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

13 (3)

2000.

1-x

objavljeno

0950-5911

Povezanost rada

Javno zdravstvo i zdravstvena zaštita

Indeksiranost